Isochorismate pyruvate-lyase (IPL) 1 , the second enzyme of pyochelin biosynthesis and the product of the pchB gene, was purified to homogeneity from Pseudomonas aeruginosa. In the reaction catalyzed by this enzyme, isochorismate → salicylate + pyruvate, no cofactors appear to be required. At the pH optimum (pH 6.8), the enzyme displayed coli mutant, which is auxotrophic for phenylalanine and tyrosine, was functionally complemented by the cloned P. aeruginosa pchB gene for growth in minimal medium. A mutant form of PchB, in which isoleucine-88 was changed to threonine, had no detectable IPL activity, but retained wild-type CM activity. In conclusion, the 11.5-kDa subunit of PchB appears to contain a single active site involved in both IPL and CM activity.
INTRODUCTION
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The nucleotide sequence of the pchB (I88T) gene on pME6179 was determined by using the Thermo Sequenase II dye terminator cycle sequencing kit (Amersham) and the ABI PRISM™ 373 sequencer.
Purification of the PchB EnzymeP. aeruginosa ADD1976/pME3324 [a T7 promoter expression vector with pchB (2)] was grown in 250 ml of nutrient yeast broth (2) containing carbenicillin (250 g/ml) in 1 liter flasks with shaking at 37°C. At A 600nm = 0.8, the chromosomal T7 RNA polymerase gene was induced for 1 h by the addition of IPTG at 1 mM final concentration. Rifampicin was then added at 200 g/ml and the incubation was continued for 2 h. All subsequent operations were carried out at 4°C. Cells from 3 flasks were harvested by centrifugation at 8000 x g for 10 min and washed twice in 50 mM K-phosphate buffer (pH 7.5) containing 10% (v/v) glycerol and 1 mM dithiothreitol (DTT) (buffer A).
Cells (wet weight 3 g), which could be stored at -20°C, were broken in 15 ml buffer A by sonication for 5 x 30 s. Cell debris was removed by centrifugation at 10,000 x g for 30 min; the resulting crude extract containing 8-10 mg of protein per ml was applied to a 1.6 x 20 cm DEAE-Sepharose CL-6B column (Pharmacia) equilibrated with buffer A. The enzyme was eluted with 300 ml of buffer A at a flow rate of 1 ml/min. The fractions containing PchB, detected by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) in 10-20% gradient gels stained with Coomassie Blue, were combined (100 ml) and loaded onto a column of Phenyl-Sepharose CL-4B (1.6 x 10 cm) previously equilibrated with 200 ml of buffer A. The enzyme was eluted as a broad peak with 150 ml of buffer A. Fractions containing PchB were pooled (80 ml) and a solution of 0.4% (w/v) n-octyl--glucopyranoside (Calbiochem) was slowly added by stirring to a final concentration of 0.1% (w/v), to avoid protein precipitation during the concentration steps.
This fraction was concentrated to 2 ml by ultrafiltration through an Amicon YM3 membrane in a stirred cell, followed by further concentration with an Amicon Centriplus C-10 concentrator (cut-off: 10,000 Da). The concentrated fraction was chromatographed on a 1.6 x 70 cm column of Bio-Gel P100 polyacrylamide gel (Bio-Rad) in buffer A at a flow rate of 6 ml/h. PchB-containing fractions were pooled, aliquoted and stored at -80°C. The protein concentration was determined by the method of Bradford (41) using a commercial reagent (Bio-Rad) and bovine serum albumin as the standard. 2 -terminal AnalysisThe subunit molecular mass of PchB was estimated by SDS-PAGE (42) in 10-20% gradient gels (Ready Gel, Bio-Rad), with standards of the Low Molecular Weight Calibration Kit (Pharmacia). The molecular mass of the native PchB was estimated by gel filtration chromatography on Sephadex G-150 (1.6 x 70 cm, 0.1 ml/min), Bio-Gel P100 (1.6 x 70 cm, 0.1 ml/min) and FPLC Superose 12 HR (10/30, 0.4 ml/min) columns in buffer A, with ribonuclease A (13.7 kDa), lysozyme (14.6 kDa), proteinase K (28.8 kDa), pepsin (34.5 kDa), protein A (42 kDa), ovalbumin (43 kDa), and bovine serum albumin (67 kDa) as markers. The elution volumes were plotted against the logarithm of molecular masses for the standards and the linear regression curve was used to estimate the apparent molecular mass of PchB.
Molecular Mass Estimation and NH
In addition, the molecular mass of native PchB was estimated from PAGE in nondenaturing gels of 7.5, 10, 12, 15 and 20% polyacrylamide, with the Low Molecular Weight Calibration Kit (Pharmacia) as a standard, by Ferguson plot analysis (43). The slopes obtained from plots of the logarithm of relative mobility versus polyacrylamide concentration were plotted against the molecular weight of the standard proteins.
The N-terminal sequence of PchB was determined by Dr. P. James (ETH, Zürich) on an Applied Biosystems, Inc. Peptide Sequencer Model 473A, using the Edman degradation procedure. with or without 40 mM DTT to cleave the crosslinks, incubated at 50°C for 3 min and subjected to SDS-PAGE on a 10-20% polyacrylamide gradient. Standard proteins (Low and High Molecular Weight Kits, Pharmacia) and the PchB control were not exposed to DTSSP, but otherwise treated in the same way.
Cross-linking of PchBSamples
Enzyme AssaysIPL activity of PchB was determined by measuring the fluorescence of salicylate formed using an excitation wavelength of 305 nm and an emission wavelength of 440 nm in a Perkin-Elmer LS30 fluorimeter. Unless stated otherwise, the incubation mixture contained, in a final volume of 500 l, 100 mM K-phosphate buffer, pH 7.0, 600 M isochorismate (purified by HPLC), 10% (v/v) glycerol, 10 mM MgCl 2 , 1 mM DTT and enzyme. Controls without enzyme were included routinely, to correct for non-enzymatic reactions. The reaction at 37°C was initiated by the addition of isochorismate and terminated by the addition of 10 l concentrated HCl, followed by extraction with 3 ml ethyl acetate.
Blanks were obtained from non-incubated reaction mixtures. The amount of salicylate formed was determined from a standard curve obtained with 0.5 to 8 M salicylic acid (Fluka) in ethyl acetate. One IPL unit of enzyme activity is defined as the amount of enzyme converting 1 mol isochorismate to salicylate per min. The reaction was stopped within the first 10% of the isochorismate-to-salicylate conversion.
CM activity of PchB was assayed by the method of Cotton and Gibson (44) as modified by Ahmad and Jensen (45). The product of the enzymatic reaction, prephenate, is converted to phenylpyruvate under acidic conditions, which is subsequently measured by its absorbance at 320 nm at basic pH. The reaction mixture contained, in a final volume of 0.2 ml, 50 mM K-phosphate, pH 7.0, 1 mM DTT, 1 mM chorismate and enzyme. Control reaction mixtures lacking enzyme were always included to estimate the amount of prephenate formed non-enzymatically during the incubation period. Reactions were carried out at 37°C and terminated by the addition of 0.1 ml of 1 M HCl, followed by incubation at 37°C for 10 min to convert the prephenate formed to phenylpyruvate. Phenylpyruvate concentrations were determined at 320 nm after the addition of 0.7 ml of 2.5 M NaOH, using ε 320nm = 17,500
M -1 cm -1 (44). One CM unit of enzyme activity is defined as the amount of enzyme needed for the formation of 1 mol prephenate (assayed as phenylpyruvate) per min.
Kinetic StudiesAssays were performed in triplicate and repeated three times.
Initial velocity data were fitted to the equations of Hanes (Table II) , Lineweaver-Burk (Fig. 3A /B/C) and Dixon using Enzpack software (Biosoft).
In Vivo CM Activity of PchBThe CM-negative E. coli strain KA12 harboring pKIMP-UAUC (47, 48) with or without pME6152 (pchB + ) was grown at 37°C with shaking in 500-ml flasks containing 100 ml minimal medium E (48), amended with 0.5% (w/v) glucose, 1 mM thiamine and 1 mM IPTG. Control cultures were grown in minimal medium E supplemented with 1 mM tyrosine and 1 mM phenylalanine. The cultures were inoculated with about 10 7 washed cells/ml, previously grown in minimal medium E supplemented with both amino acids, ampicillin (100 g/ml) and chloramphenicol (25 g/ml). Cell growth was monitored by following the OD 600nm . (Table II) .
Western Immunoblot Procedure
As sequence comparisons pointed to a possible relationship of PchB to CMs of the AroQ class, purified PchB enzyme was assayed with chorismate as the substrate.
Interestingly, the enzyme displayed CM activity and showed Michaelis-Menten kinetics with chorismate as the substrate (Table II) . The K m value for chorismate (150 M) was higher than that for isochorismate (12.5 M), whereas the k cat value calculated per monomer was lower for the Claisen rearrangement of chorismate (7.8 min -1 ) than that for the isochorismate-tosalicylate conversion (106 min -1 ), suggesting that PchB primarily functions as an IPL rather than as a CM. (Table II) . This result suggests and raises the possibility that the IPL and CM activities of PchB involve a shared active site.
Inhibitors of
Chorismate was a weak competitive inhibitor of the IPL reaction (Fig. 3C) , with a K i of 400 M, as determined by a Dixon plot (Table II) In the presence of 1 mM IPTG, but not in the absence of the inducer, PchB was produced at high levels in E. coli as revealed by Western blotting ( Fig. 4; lanes 2 + 3) . Under inducing conditions, PchB represented about 5% of the total soluble protein in E. coli (data not shown).
Moreover, PchB allowed functional complementation of the CM deficiency, i.e., growth in unsupplemented minimal medium. The parent strain E. coli KA12/pKIMP-UAUC grew only when phenylalanine and tyrosine were added to the minimal medium. When this strain carried pME6152, growth occurred in minimal medium without phenylalanine and tyrosine, provided that IPTG was added (Table III) . However, the doubling time t d (240 min) was about 3 times longer than that observed in minimal medium with added phenylalanine and tyrosine (80 min), suggesting that PchB could only partially complement the CM deficiency of the E. coli host (Table III) .
The minimal medium used does not contain added iron (48). Under these conditions, we expect the iron-repressible entC gene, which encodes ICS in the E. coli host, to be derepressed (52). This facilitates the rapid interconversion of the intracellular pools of chorismate and isochorismate (53, 35). Conversion of isochorismate to the thermodynamically favored salicylate by the IPL activity of PchB may therefore efficiently deplete the chorismate pool, which could result in the inability of PchB to fully complement the CM-deficiency (see Fig. 1 ). Thus, under iron limitation, PchB would mostly function as an IPL, rather than as a CM. This scenario is consistent with the significant increase in growth rate of E. coli KA12/pKIMP-UAUC + pME6152 when 100 M FeCl 3 was added to the medium (Table III) . The mutated pchB gene of pME6179 was sequenced and a T:A to G:C transversion was identified at nucleotide 263, leading to a replacement of isoleucine-88 with threonine.
Isolation of an IPL-Defective Mutant Form of PchBIn
The affected position is not among those conserved between the PchB polypeptide and CMs of various origins (27). PchB showed the greatest similarity to the CM moiety (the AroQdomain) of AroQ•TyrA from Haemophilus influenzae (26.3% identity) and to the same enzyme from E. coli (24.7% identity). PchB also shows similarity (17% identity) to the CM moiety of AroQ•PheA (the P-protein) of E. coli (Fig. 5) .
The catalytic properties of PchB I88T were compared to the ones of wild-type PchB in cell extracts of E. coli. The apparent K m values obtained under these conditions for wild-type
D I S C U S S I O N
The PchB protein, the first IPL purified from any organism, is a small enzyme. Its 101-amino acid subunit forms a homodimer, as suggested by the cross-linking experiments shown in Fig. 2 . IPL catalyzes the second reaction in the pyochelin biosynthetic pathway of P. aeruginosa, following the initial PchA-dependent conversion of chorismate to isochorismate [(2), Fig. 1 ]. We discovered that PchB can also carry out the CM-reaction (Fig.   1 ), in vitro and in vivo. However, the catalytic efficiency (k cat /K m ) of this reaction is more than two orders of magnitude lower than that of the IPL reaction (Table II) . Moreover, while
PchB's K m for chorismate is in the range of the Michaelis constants of other typical CMs (27, 54, 55), its catalytic rate constant k cat is significantly smaller by two to three orders of magnitude. When PchB was overproduced at a level about 5% of the total soluble protein in E. coli, its CM function (or that of the selected IPL-deficient variant PchB I88T ) was apparently the growth-limiting factor when the recombinant organism was cultivated in minimal medium (Table III) . It is therefore unlikely that PchB plays a significant role in aromatic amino acid biosynthesis of P. aeruginosa, even under conditions of derepression of the pchDCBA operon, i.e. when iron is limiting (22) .
PchB structurally resembles CMs of the AroQ class in several respects. First, the length of the PchB sequence corresponds to the typical length of an AroQ domain, and the degree of sequence similarity of PchB with other AroQ proteins is in the range of similarities among other CMs of the AroQ family (27, 31). Second, secondary structure analysis using a neural network (56) predicts that PchB has the same all-α-helical structural organization as the CM moiety of AroQ•PheA from E. coli (Fig. 5) . The crystal structure of the latter enzyme has been solved as a complex with TSA (51). It is an elongated dimer formed by two identical subunits which are composed of three α-helices each. Two symmetrical active sites at the dimer interface bury the ligand in the core of a four-helix-bundle motif. Third, the quaternary structure of PchB was found to be dimeric, too, resulting in a similar abnormal migration behavior in gel filtration experiments as described previously for the monofunctional dimeric AroQ-class CM from M. jannaschii ( (Table II) . Third, chorismate and isochorismate, the two alternative substrates of PchB, are distinguished only by the position of their respective hydroxyl groups ( Fig. 1) , leaving most of the functional groups and overall geometry of the substrates available for common binding interactions in the active site.
From the structural and functional correspondences it is clear that there can only be a single type of active site in PchB to which both substrates must bind and which carries out the Claisen rearrangement of chorismate in addition to the conversion of isochorismate to salicylate and pyruvate. Using the three-dimensional structure of E. coli AroQ•PheA (51) complexed with TSA as a template (Fig. 6A) , we built a model of the active site of PchB with bound isochorismate (Fig. 6B) (Table II) may well be a consequence of this structural feature. Other differences between the active sites are apparent in the region of the 2-hydroxyl group of isochorismate. Interestingly, the residue mutated in the selected variant PchB I88T is located in this area (Fig. 6B) . The exchange of isoleucine at position 88 by a threonine may prevent productive binding of isochorismate and thereby explain abolishment of all IPL activity.
Since chorismate lacks a substituent at position 2, the mutation does not necessarily interfere with chorismate binding. The unchanged K m for the CM reaction of PchB I88T (Table III) is in agreement with this view.
Based on our observations, we speculate that PchB was derived from an AroQ-class CM by a gene duplication event followed by selection for efficient IPL function in the course of the evolution of the pyochelin siderophore pathway. From the fact that PchB can still use the same active site either for the IPL or for the CM reaction, it appears that the active site of the ancestral CM needed only modest alteration to be turned into an efficient IPL.
Nevertheless, the required changes had a pronounced deleterious effect on the CM activity. 
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